SGS is proud to be Award Sponsor at ACDM 2022. Visit us at booth 16 to find out more about our biometric services and clinical research solutions.
Join SGS at the ACDM Conference
The Association for Clinical Data Management (ACDM) Annual Conference has been running for over 30 years. This year, ACDM22 will take place at the Sheraton Grand Hotel in Edinburgh, Scotland. The conference offers a full two day program of expert speakers, specialist panels, workshops and debates, focusing on current topics in the field of clinical data management.
Our experts from Biometrics will be presenting on different topics:
- Embracing the SDTM mindset at Study Start to mitigate compliance issues, presented by Els Janssens (Executive Manager Secure Data Office, SGS Health Science) - March 14 - 13:45 Parallel Session 1
- eSource arising: clinical data automation possibilities beyond data capture, presented by Sofie Stynen (Clinical Data Manager Coordinator, SGS Health Science) and Annelies Van Zeveren (Project Director Biometrics & Medical Safety - Regulatory) March 15 - 12:00 - Parallel Session 2.4
Visit our experts at booth 16 to find out more about our biometric services and clinical research solutions.
About SGS Health Science
SGS is a leading contract service organization offering clinical research and bioanalytical testing with specific focus on early stage development and biometrics. Delivering solutions in Europe and the Americas, we offer clinical trial (Phase I to IV) services encompassing:
- Clinical project management and monitoring
- Medical writing
- Data management
- Secure data office
- PK/PD data analysis
- Medical Safety
The SGS biometric group is organized for flexible allocation to meet the needs of small, medium and large pharma companies. Our EDC team has extensive experience in customized eCRF build, interactive web response systems and electronic clinical outcome assessment. SGS is a CDISC registered solution provider and has successfully submitted full electronic submissions for FDA, EMA and PMDA for several candidate drugs.
For further information, please contact:
t: +32 15 27 32 45